Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7XV4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,316
Award facts
- Contract value 100% obligated
- $23,316.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 21, 2026, for Dupixent 300 mg/2 ml syringes with a ceiling value of $23,316.16 under a firm fixed-price structure.
Place of performance is Conshohocken, PA. The order is expected to complete by April 22, 2026. No set-aside was used. This delivery order is issued against Amerisourcebergen's standing indefinite delivery contract with DLA Troop Support Medical for pharmaceutical supply and distribution supporting military healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F7XV4?
SPE2DR26F7XV4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 21, 2026.
How much is contract SPE2DR26F7XV4 worth?
The government has obligated $23,316 on SPE2DR26F7XV4.
Is contract SPE2DR26F7XV4 an order under another contract?
Yes. SPE2DR26F7XV4 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7XV4 competed?
The extent of competition for SPE2DR26F7XV4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award